Partnering News
04/24/12, Bayer HealthCare Bayer expands targeted cancer therapy collaboration with Amgen more
03/27/12, Bayer HealthCare Bayer HealthCare and Beijing’s Tsinghua University extend innovative drug discovery partnership more
01/28/11, Bayer HealthCare Bayer and Zydus Cadila sign Joint Venture Agreement to strengthen pharmaceutical business in India more
06/02/09, Bayer HealthCare Pharmaceuticals Bayer HealthCare and Genzyme Finalize Strategic Alliance Agreement more
04/30/09, Bayer HealthCare Bayer and Regeneron extend development program for VEGF Trap-Eye Two phase III studies in Central Retinal Vein Occlusion (CRVO) to begin in the second half of this year more
03/31/09, Bayer HealthCare Pharmaceuticals Bayer HealthCare and Genzyme Corporation Enter New Strategic Agreement Agreement improves profitability and strategic focus in key Bayer therapeutic areas / Licenses hematological cancer products to Genzyme / Continues co-development partnership for alemtuzumab in multiple sclerosis (MS) / Bayer maintains worldwide co-promotion rights for alemtuzumab in MS – distribution rights returned to Genzyme / Bayer to receive substantial licensing, milestone payments from Genzyme over the duration of the agreement more
- Age-related macular degeneration (AMD)
- Breast cancer
- Central retinal vein occlusion (CRVO)
- Colorectal Cancer (CRC)
- Contraception
- Diabetes
- Diabetic macular edema (DME)
- Endometriosis
- Erectile dysfunction
- Gastrointestinal stromal tumor (GIST)
- Gynecological therapy
- Heart attack
- Heartattack and stroke
- Hemophilia
- High blood pressure
- Infectious diseases
- Liver cancer
- Lung cancer
- Menopausal complaints
- Multiple sclerosis
- Peripheral arterial occlusive disease
- Premenstrual dysphoric disorder (PMDD)
- Prostate cancer
- Pulmonary arterial hypertension
- Renalcell carcinoma
- Stroke
- Testosterone deficiency
- Thrombosis
- Thyroid Cancer
Page tools
- B/W version
- A | A | A | Font size
